αmethylacylcoa racemase amacr ec enzyme humans encoded amacr amacr catalyzes following chemical reaction mammalian cells enzyme responsible converting esters epimers known substrates including coenzyme esters pristanic acid mostly derived phytanic acid branchedchain fatty acid abundant diet bile acids derived cholesterol transformation required order degrade esters βoxidation process requires enzyme known localised peroxisomes mitochondria known βoxidize enzyme belongs family isomerases specifically racemases epimerases act compounds systematic name enzyme class vitro experiments human enzyme amacr show esters substrates converted enzyme similar efficiency prolonged incubation either substrate enzyme establishes equilibrium substrates products present near ratio mechanism enzyme requires removal αproton form deprotonated intermediate probably enol followed nonsterespecific thus either epimer converted near mixture isomers upon full conversion substrate decreased increased levels enzyme humans linked diseases reduction protein level activity results accumulation fatty acids bile acids causes neurological symptoms symptoms similar adult refsum disease usually appear late teens early first documented cases amacr deficiency adults reported deficiency falls within class disorders called peroxisome biogenesis disorders pbds although quite different peroxisomal disorders share classic refsum disorder symptoms deficiency causes accumulation pristanic acid dihydroxycholestanoic acid dhca trihydroxycholestanoic acid thca lesser extent phytanic acid phenomenon verified researchers reported certain case condition would missed hadnt measured pristanic acid amacr deficiency cause mental impairment confusion learning difficulties liver damage treated dietary elimination pristanic phytanic acid reduced intake dairy products meats beef lamb chicken compliance diet low however eating habits loss increased levels amacr protein concentration activity associated prostate cancer enzyme used widely biomarker known cancer literature biopsy tissues around different variants human amacr identified prostate cancer tissues variants arise alternative mrna splicing splice variants lack catalytic residues active site changes cterminus required dimerisation increased levels amacr also associated breast colon cancers unclear exactly role amacr antibodies amacr used immunohistochemistry demonstrate prostate carcinoma since enzyme greatly overexpressed type enzyme also involved chiral inversion pathway converts ibuprofen member acid nonsteroidal antiinflammatory drug family nsaids renantiomer senantiomer pathway unidirectional ribuprofen converted ibuprofenoylcoa epimerized amacr conversion sibuprofenoylcoa sibuprofen assumed performed one many human acylcoa thioesterase enzymes acots reaction pharmacological importance ibuprofen typically used racemic mixture drug converted sisomer upon uptake inhibits activity cyclooxygenase enzymes induces antiinflammatory effect human amacr demonstrated epimerise suggesting common chiral inversion pathway class drugs httpsenwikipediaorgwikialphamethylacylcoaracemase